Search Result
List
2016-09-30 - 2019-12-31
Phase II
-
Condition/Disease
Active psoriatic arthritis
-
Test Drug
BI655066
Participate Sites
9Sites
Terminated7Sites
Division of Rheumatology
2015-09-01 - 2018-03-01
Phase II
-
Condition/Disease
Locally Advanced or Metastatic Breast Cancer
-
Test Drug
BI 836845
Participate Sites
4Sites
Terminated4Sites
Division of General Surgery
2015-11-01 - 2017-10-31
Phase III
-
Condition/Disease
Stage IIIB/IV Non-small Cell Lung Cancer Tumors with EGFR Activating Mutations
-
Test Drug
ASP8273
Participate Sites
9Sites
Terminated9Sites
Division of Hematology & Oncology
Division of Thoracic Medicine
2017-05-01 - 2023-10-30
Phase III
-
Condition/Disease
NSCLC
-
Test Drug
Nivolumab (BMS-936558),Ipilimumab (BMS-734016)
Participate Sites
16Sites
Terminated14Sites
Division of Thoracic Medicine
2015-07-01 - 2023-10-27
Phase III
-
Condition/Disease
Renal Cell Carcinoma
-
Test Drug
Nivolumab (BMS-936558)
Participate Sites
3Sites
Terminated3Sites
Division of Hematology & Oncology
Division of Hematology & Oncology
2018-10-01 - 2021-08-31
Phase II
-
Condition/Disease
Advanced Pancreatic Cancer
-
Test Drug
Cabiralizumab (BMS-986227, FPA008)
Participate Sites
2Sites
Terminated2Sites
Digestive System Department
2019-05-24 - 2021-12-31
Phase I
-
Condition/Disease
-
Test Drug
Participate Sites
3Sites
Recruiting3Sites
Division of Obstetrics & Gynecology
2016-04-01 - 2018-12-04
Phase I
-
Condition/Disease
Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck
-
Test Drug
NC-6004
Participate Sites
3Sites
Terminated3Sites
Division of Hematology & Oncology
Division of Hematology & Oncology
2019-03-01 - 2021-07-31
Phase III
-
Condition/Disease
-
Test Drug
Participate Sites
1Sites
Terminated1Sites
Division of Cardiovascular Diseases
